Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue:    
Revenue
Other revenue 940 622
Total revenue 940 622
Operating expenses:    
Research and development, net of reimbursements 4,369 4,276
General and administrative 1,735 1,718
Total operating expenses 6,104 5,994
Loss from operations (5,164) (5,372)
Other income:    
Interest income - net 35 52
Total other income 35 52
Net loss $ (5,129) $ (5,320)
Net loss per share of common stock – basic and diluted (in Dollars per share) $ (0.23) $ (0.29)
Weighted average shares of common stock outstanding – basic and diluted (in Shares) 22,143,974 18,375,442